Equities

Cue Health Inc

HLTH:NSQ

Cue Health Inc

Actions
  • Price (USD)2.49
  • Today's Change-0.09 / -3.49%
  • Shares traded126.52k
  • 1 Year change-75.12%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2022 18:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Cue Health Inc. is a health technology company. The Company has developed a platform, the Cue Integrated Care Platform, with a focus on user experience, convenience, and accuracy. The Cue Integrated Care Platform consists of hardware and software components: Cue Health Monitoring System includes Cue Reader, made up of a portable, durable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand a sample collection wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its consumer-friendly Cue Health App and its Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors. Its product offering is Cue COVID-19 Test. Its COVID-19 test, consist Cue Reader and COVID-19 Test Kit (Cue COVID-19 Cartridge and Cue Wand), is designed to detect SARS-CoV-2, the virus that causes COVID-19.

  • Revenue in USD (TTM)683.30m
  • Net income in USD-42.67m
  • Incorporated2010
  • Employees1.59k
  • Location
    Cue Health Inc4980 Carroll Canyon Road, Suite 100SAN DIEGO 92121United StatesUSA
  • Phone+1 (858) 412-8151
  • Fax+1 (302) 636-5454
  • Websitehttps://cuehealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Edgio Inc316.31m-83.65m332.38m1.26k--1.13--1.05-0.4838-0.48381.971.330.7142--3.75573,029.00-18.89-7.33-23.70-8.5631.4939.50-26.44-8.40---11.330.293---5.465.28-184.07--10.58--
Advant-E Corporation10.11m2.00m337.65m67.00----147.5133.41604.19604.193,046.291,545.221.56--12.07150,836.6030.7924.2237.8630.7060.8160.3619.8016.24----0.0090.615.407.1316.9114.38-15.14--
Babylon Holdings Ltd725.96m-542.01m337.89m2.89k------0.4654-1.31-1.311.76-0.14282.15--25.67251,544.70-162.16---243.57---0.4663---75.38-----14.111.26--307.36---97.26------
Ealixir Inc10.75m-307.02k343.23m7.00----409.9131.93-1.22-1.2219.38-22.474.4074.6016.52--18.22------6.81--4.14--0.0066-9.74-----31.91--97.12------
Lzg International Inc2.65m-4.62m343.55m0.00--24.91--129.69-0.0447-0.04470.05260.09030.1433-------24.98-9.52-49.06-12.3785.91---174.37-473.670.2808-13.350.5168-------2,982.41------
Appgate Inc68.20m-132.71m343.98m472.00--70.6954.385.04-3.38-1.880.82880.03690.8701----144,493.60-169.32---235.90--48.89---194.59-----14.730.951--------------
NeoGames SA108.73m-21.73m346.26m156.00--2.57143.563.18-0.7983-0.79833.935.210.3787--6.09696,987.20-8.67---11.42-------22.90------0.6023--2.56---28.58------
ON24 Inc196.34m-55.59m356.51m717.00--1.13--1.82-1.17-1.174.136.580.4277--5.77273,834.00-12.11---16.04--73.37---28.31-----268.430.0065--29.74---712.24------
Benefitfocus Inc249.11m-24.82m356.94m1.10k----205.381.43-0.7287-0.72877.37-0.72311.02--5.97226,460.00-7.58-14.42-10.56-20.0050.3550.63-7.40-15.49--0.14681.27---1.882.15-37.94---1.51--
Rimini Street Inc400.32m69.37m369.88m1.66k6.33--4.910.9240.66240.66244.31-0.85441.36--5.91241,156.6024.692.77571.54--62.9162.3118.201.90--7.88121.99--14.5818.51396.90--12.15--
Innovid Corp119.39m-46.67m371.55m396.00--1.81--3.11-0.384-0.3840.92471.540.7484--3.21301,479.80-14.17---15.98--76.89---18.93------0.0682--31.24---991.81------
Cue Health Inc683.30m-42.67m372.09m1.59k--0.5748--0.5446-0.2882-0.28824.644.330.88433.7614.49431,100.90-5.52---7.25--44.39---6.24--2.290.34080.0071--2,592.93--282.50------
Rubicon Technologies Inc0.00-1.72m395.04m----0.3054-----0.037-0.0370.007.860.00-------1.07---1.07--------------0.00--------------
Skillz Inc335.88m-386.24m405.42m650.00--0.9372--1.21-0.9544-0.95440.82741.030.4242--30.92516,733.80-48.78---53.27--89.80---115.00-----15.610.3862--66.91---24.65------
Shotspotter Inc73.98m4.12m414.42m167.00106.527.0032.645.600.3190.3196.084.860.8328--4.41442,970.104.64-9.407.92-20.6057.2857.255.57-11.77----0.00--27.1630.26-461.71--11.64--
Data as of Nov 25 2022. Currency figures normalised to Cue Health Inc's reporting currency: US Dollar USD

Institutional shareholders

30.73%Per cent of shares held by top holders
HolderShares% Held
Koch Industries, Inc. (Investment Management)as of 30 Sep 202213.18m8.90%
Oakmont Corp.as of 30 Sep 20229.60m6.48%
BlackRock Fund Advisorsas of 30 Sep 20225.74m3.87%
Jabodon Pt Co.as of 30 Sep 20224.57m3.09%
The Vanguard Group, Inc.as of 30 Sep 20223.95m2.66%
Temasek Holdings Pte Ltd. (Investment Management)as of 30 Sep 20223.13m2.11%
Geode Capital Management LLCas of 30 Sep 20221.87m1.27%
SSgA Funds Management, Inc.as of 30 Sep 20221.65m1.11%
Bleichroeder LPas of 30 Sep 20221.00m0.68%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2022853.70k0.58%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.